CC
TNDM icon

Centiva Capital’s Tandem Diabetes Care TNDM Stock Holding History

Centiva Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,001
Closed -$1.14M – 1846
2025
Q2 		$1.14M Buy
+61,001
New +$1.21M 0.02% 555
2023
Q3 		– Sell
-14,034
Closed -$344K – 2093
2023
Q2 		$344K Buy
+14,034
New +$451K 0.01% 1043
2022
Q4 		– Sell
-9,459
Closed -$453K – 1625
2022
Q3 		$453K Buy
+9,459
New +$519K 0.01% 907
2020
Q1 		– Sell
-6,099
Closed -$364K – 909
2019
Q4 		$364K Buy
+6,099
New +$376K 0.02% 513

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Centiva Capital's TNDM Position: Q3 2025 in Review

Centiva Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 61,001 shares — an estimated $1.14M sold.

Centiva Capital first reported a position in TNDM in Q4 2019 and held it in 4 quarters. The position peaked at $1.14M in Q2 2025. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Centiva Capital reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 61,001 Tandem Diabetes Care shares in Q3 2025, an estimated $1.14M.
  • Centiva Capital first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 4 quarters.
  • Centiva Capital's Tandem Diabetes Care position peaked at $1.14M in Q2 2025.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.